KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Palvella Therapeutics, Inc. (PVLA) Other Working Capital Changes (2016 - 2022)

Palvella Therapeutics (PVLA) has disclosed Other Working Capital Changes for 11 consecutive years, with $1.3 million as the latest value for Q4 2024.

  • On a quarterly basis, Other Working Capital Changes rose 103.7% to $1.3 million in Q4 2024 year-over-year; TTM through Dec 2024 was $1.5 million, a 650.55% increase, with the full-year FY2024 number at $1.5 million, up 650.55% from a year prior.
  • Other Working Capital Changes was $1.3 million for Q4 2024 at Palvella Therapeutics, up from $134000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $36.9 million in Q4 2021 to a low of -$43.5 million in Q2 2021.
  • A 5-year average of $293700.0 and a median of $307000.0 in 2022 define the central range for Other Working Capital Changes.
  • Peak YoY movement for Other Working Capital Changes: plummeted 739.54% in 2021, then surged 3341.02% in 2023.
  • Palvella Therapeutics' Other Working Capital Changes stood at -$14.3 million in 2020, then surged by 358.49% to $36.9 million in 2021, then tumbled by 171.46% to -$26.4 million in 2022, then fell by 29.08% to -$34.1 million in 2023, then soared by 103.7% to $1.3 million in 2024.
  • Per Business Quant, the three most recent readings for PVLA's Other Working Capital Changes are $1.3 million (Q4 2024), $134000.0 (Q3 2024), and $163000.0 (Q2 2024).